ArticleBreast cancer research : BCR2021

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.

Adrián Sanz-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.